A role for ionizing radiation in myelomagenesis?

Blood

Volumn 113, Issue 8, 2009, Pages 1616-1617

  Landgren, Ola ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC BOMB SURVIVOR; CARCINOGENESIS; CHROMOSOME ABERRATION; COMPUTER ASSISTED TOMOGRAPHY; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; HUMAN; INCIDENCE; IONIZING RADIATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMAGENESIS; NOTE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIATION EXPOSURE; RADIOSENSITIVITY; SCREENING TEST;

EID: 61949171424     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-11-186957     Document Type: Note

References (12)

1. Alexander DD, Mink PJ, Adami HO, etal. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007;120 (suppl 12):40-61.
2. Shimizu Y, Schull WJ, Kato H.Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. JAMA. 1990;264: 601-604.
3. Preston DL, Kusumi S,Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994;137:S68-S97.
4. Ichimaru M, Ishimaru T, Mikami M, et al. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow. J Natl Cancer Inst. 1982;69:323-328.
5. Pasqualetti P, Collacciani A, Casale R. Risk of monoclonal gammopathy of undetermined significance: a case-referent study. Am J Hematol. 1996;52:217-220.
6. Neriishi K, Nakashima E, Suzuki G. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma. Br J Haematol. 2003;121:405-410.
7. Iwanaga M, Tagawa M, Tsukasaki K, et al. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. Blood. 2009;113:1639-1650.
8. Wright EG, Coates PJ. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat Res. 2006;597:119-132.
9. Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2:175-187.
10. Landgren O, Kyle RA. Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases. Br J Haematol. 2007;139:717-723.
11. Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111: 3388-3394.
12. Semelka RC, Armao DM, Elias J Jr, et al. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging. 2007;25:900-909.